We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

World's First Cooperatively Powered Robotic Surgical Assistant Platform Facilitates ENT Procedures

By HospiMedica International staff writers
Posted on 27 Sep 2023

While medical robots are becoming more common in surgical settings, there are still many surgeons who perform operations manually, relying on their skills to stabilize their hands and minimize tremors. Now a new surgical robotic assistant is designed to assist such surgeons in soft tissue surgeries by acting as a support for performing ear, nose, and throat (ENT) surgeries.

Galen Robotics (Baltimore, MD, USA) has developed the Galen ES robotic system which is the world’s first cooperatively powered surgical assist device for ENT surgery. The system helps ENT surgeons with tasks like instrument positioning in combination with Microlaryngeal Alligator Forceps. The device synchronizes with the surgeon's actions to aid in the precise and stable positioning of surgical instruments, all while the surgeon retains direct physical control over them. The aim of the Galen ES system is to offer increased stability for instruments in complex microlaryngeal surgeries, enabling otolaryngologists to potentially deliver better patient outcomes with its high functionality and quick setup time.


Image: The Galen ES is a cooperatively powered surgical assist device for ENT surgery (Photo courtesy of Galen Robotics)
Image: The Galen ES is a cooperatively powered surgical assist device for ENT surgery (Photo courtesy of Galen Robotics)

The Galen ES system is designed to assist surgeons in moving the Microlaryngeal Alligator Forceps to a chosen location within the surgical area and keep it in place until the surgeon decides to move it. The system is meant for use in rigid microlaryngeal surgeries carried out by skilled otolaryngologists on patients who are at least 18 years old and are in an operating room environment. After securing a De Novo classification grant and market authorization from the U.S. Food and Drug Administration (FDA) for the Galen ES robotic system for use in rigid microlaryngeal procedures, Galen Robotics aims to push the boundaries of surgical medicine. The company is focused on innovating surgical methods and offering groundbreaking solutions to healthcare providers. The primary objective of Galen's technology is to assist in surgeries where operating room space is restricted and sensitive anatomical structures must be handled with extreme care.

"Our team is incredibly proud the Galen ES Robotic System was granted FDA clearance in record time," announced Bruce W Lichorowic, President & CEO of Galen Robotics, Inc. "The Galen ES System holds great promise in revolutionizing challenging ENT surgeries by providing existing surgical instruments with its advanced features that empower skilled ENT surgeons. We anticipate significantly improved surgical precision and better patient outcomes."

Related Links:
Galen Robotics


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Adjustable Shower Trolley
ST 370
New
Blanket Warming Cabinet
EC250

Latest Surgical Techniques News

Revolutionary Robotic Surgery Combines Dual-System Technologies for Groundbreaking Prostate Procedure

Robotic-Assisted and AR Spine Surgery Enable Equally High Degree of Precision and Accuracy, Finds Study

Magnetically Driven Robotic Microscrews for Fallopian Tube Blockages to Revolutionize Infertility Treatment